4521 科研製薬 企業サイト   Yahooファイナンス 日経新聞 株探 四季報

基本データ
【業種】医薬品
【市場】プライム(内国株式)
【決算期】3月
【会社設立】1948.3
【上場】1961.10
【直近決算日】2024-11-08
【決算予定日】

【時価総額】2038億8100万円
【予想PER】11.84 倍
【PBR】1.09 倍
【自己資本比率】82.5 %
業績予想(通期のみ)
年度タイプ日付売上高営業利益経常利益純利益
2023-03新規2022-05-1176400150001550012000
修正2023-02-0373500(↓)7500(↓)8100(↓)6100(↓)
2024-03新規2023-05-1073100760080006700
2025-03新規2024-05-1475100740078005600
修正2024-08-0788500(↑)20800(↑)21200(↑)14200(↑)

 ※来期予想のグラフはQ1と表記されているがQ4である。

決算期四半期売上高営業利益経常利益純利益1株当たり純利益営業利益率経常利益率売上高/前年比営業利益/前年比経常利益/前年比純利益/前年比
予想8850020800212001420023.5%23.95%22.8%118.6%113%76.9%
2025-03251372195791982314286377.2338.11%38.59%42%255.2%246.4%251.2%
11825427503011175446.3215.07%16.5%0.6%-16.5%-13.7%-30.1%
2024-03472044951399518025212.6713.2%13.81%-1.3%18.9%14%47.5%
354685887393046675177.116.23%17.01%-1.6%-28.4%-28.3%-27%
236171551257224068108.1815.24%15.82%-1.8%-32.8%-33.1%-31.8%
11815032933488251066.9918.14%19.22%-0.3%-18.8%-19.5%-13.7%
2023-03472984799887275440144.810.96%11.96%-4%-53.1%-50.3%-43%
35557312394129769149243.3122.3%23.35%-3.7%-10.8%-9.4%-10.7%
236819820985555964158.3422.3%23.24%-2%-9.2%-7.9%-11.3%
11819740564332290776.9122.29%23.81%-1.4%-8.3%-7%-13.5%
2022-0347603417064175429549251.4322.44%23.07%1.4%-4.1%-3.7%-28.8%
357708138891432210246269.4124.07%24.82%1.1%-7.1%-6.7%-6.3%
237588903692906721176.2424.04%24.72%2.2%-7.6%-7.2%-7%
11845344214660336287.7823.96%25.25%2.1%-12.1%-11.2%-12%
2021-03474979177881822213405347.3723.72%24.3%-16%-32.9%-32.4%-30.8%
357082149491534710934282.6926.19%26.89%-18.7%-33.4%-32.8%-29.7%
2367899782100107226186.1526.59%27.21%-18.6%-28.8%-28.1%-24.3%
11807050315249382098.1827.84%29.05%-19.1%-25%-23.9%-20.8%
2020-03489232265122694619370494.8929.71%30.2%-5.2%7.8%7.9%9%
370178224322282915554396.6731.96%32.53%-3.3%12.7%12.7%9.2%
24517013744139299547242.5630.43%30.84%-4.9%11.2%11.1%8%
122335670568984826121.6530.02%30.88%-7.5%18.7%18.6%19.6%
2019-03494165245922497217775445.7826.12%26.52%-4.3%-10.6%-10.3%-6.7%
372584199032025414247356.8427.42%27.9%-5.6%-16%-15.8%-15.5%
24752112356125368840220.8426%26.38%-4.7%-19.4%-19.2%-18.7%